Tag Archives: bitopertin

Roche Hits First Two of Three

Roche had been approaching a Trifecta of datasets and decision points that would determine whether their steadfast focus on innovative R&D in neuroscience would be sustained. Now, it seems certain that it will be, because the Company had success in … Continue reading

Posted in Big Pharma | Tagged , , , , , , | Leave a comment